Loading clinical trials...

SuperNO2VA™ and General Anesthesia Postoperative Care | Clinical Trials | Clareo Health

UNKNOWNNA

SuperNO2VA™ and General Anesthesia Postoperative Care

SuperNO2VA™ and General Anesthesia Postoperative Care: Comparing the Incidence, Severity, and Duration of Postoperative Oxygen Desaturation Between SuperNO2VA™ and Standard of Care, a RCT

NCT03969615•Vyaire Medical

View on ClinicalTrials.gov

Summary

The purpose of the study is to randomly and prospectively evaluate the differences in outcomes between the control group (closed full facemask immediate post-extubation with standard oxygenating device used post-operatively in PACU) and the SuperNO2VA™ group (SuperNO2VA™ immediate post-extubation and post-operatively in PACU)

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age 18 years of age or older
•2. Patients scheduled for general anesthesia with a supraglottic device or ETT
•3. American Society of Anesthesiology (ASA) Physical Status I-IV (E)
•4. Has provided written informed consent
•5. BMI \> 35 kg/m2 or documented Obstructive Sleep Apnea

Exclusion Criteria

•1. Inability to give informed consent
•2. ASA V (E)
•3. Allergy to Propofol
•4. Any condition, in the Investigator's opinion, that would conflict or otherwise prevent the subject from complying with study required procedures, schedule or other study conduct
•5. BMI \< 35 kg/m2 with no documented diagnosis (known) of Obstructive Sleep Apnea
•6. Known diagnosis of moderate to severe COPD/lung disease
•7. Patients that remained intubated post-operatively
•8. Patient refusal to wear the treatment device (SuperNO2VA™, nasal cannula, or oxygen facemask) for the duration of the study period postoperatively

Locations (1)

The University of Texas, MD Anderson Cancer Center

Houston, Texas, United States

Key Dates

Start Date

October 15, 2018

Primary Completion Date

October 15, 2019

Completion Date

October 15, 2019

Last Updated

June 3, 2019

Enrollment

150

ESTIMATED participants

Conditions

HypoxemiaAcute Respiratory Failure

Interventions

SuperNO2VA nasal positive airway pressure devic

DEVICE

Supplemental oxygen

DEVICE

Contacts

Carin Hagberg, MD

CONTACT

7135633511 chagberg@mdanderson.org

Shannon Hancher-Hodges, MD

CONTACT

shancher@mdanderson.org

Health Systems and Policy Contexts of Medical Oxygen

NCT06169514

HypoxemiaMorality+1 more

View study

RECRUITINGNA

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

NCT06432881

Hypoxemia

View study

RECRUITINGNA

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 3, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

SuperNO2VA™ and General Anesthesia Postoperative Care

Inclusion Criteria

Exclusion Criteria

Health Systems and Policy Contexts of Medical Oxygen

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

Global Physiotherapy in ICU Patients With High Risk Extubation Failure

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Postoperative Respiratory and Activity Monitoring